Application of low-frequency electrostatic field in clinical practice

Куликов, А Г; Yarustovskaya, O V; Kuzovleva, Ekaterina V.; Zaitseva, Tatiana N.; Kulchitskaya, D B; Кончугова, Т В

doi:10.17816/1681-3456-2019-18-3-195-209

Cited by 10 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Deep Oscillation® therapy is suitable for diseases of the musculoskeletal system of a traumatic, degenerative and inflammatory pattern (Kulchitskaya et al (2019); Vakhova et al (2022)), post bone fractures, in surgical practice (Kulchitskaya D.B. et al (2020), during osteotomy, joint alloplastic, prevention of decubitus (Li A.A. et al (2009); Khodyreva et al (2012); Vladeva et al ( 2021)) diseases of the peripheral nervous system -dorsopathies (Valeyev & Minenko (2010)) central nervous systemconsequences of vascular and traumatic damage of brain and spinal cord, multiple sclerosis, migraine (Kulikov et al ( 2019)), diseases of the cardiovascular system -hypertensive disease, chronic venous and lymphatic insufficiency, lymphedema (Abramovich et al (2006)), diseases of the respiratory system: bronchial asthma, COPD, chronic bronchitis, pneumonia, cystic fibrosis.…”

Section: Introductionmentioning

confidence: 99%

Deep Oscillation® Therapy - Can It Be Effective in Patients With Covid-19 and Post - Covid Syndrome

Мratskova

2022

MEDIS

View full text Add to dashboard Cite

Treatment of patients with COVID-19, prevention of respiratory and other affected systems complications, prevention of multisystem damage and faster recovery possibilities and disease consequences overcoming is a particularly relevant topic today, when the number of people who have suffered from acute coronavirus infection is increasing. A tendency to shift the focus from acute manifestations to long-term morbidity and chronic involvement of various organs and systems is observed. In these subacute and chronic phases of illness, the application of physical modalities would be potentially effective. Traditionally, physical and rehabilitation medicine deals with patients with combined pathologies in order to reduce the duration of treatment and to speed up after-illness recovery. Deep Oscillation® therapy is a relatively new physical modality that is successfully applied to a number of diseases, including inflammatory pathologies of respiratory and musculoskeletal system, trauma, burns, fibrosis prevention, edema reduction, muscle relaxation etc. The purpose of this article is to make a review of the potential therapeutic effects of the Deep Oscillation® therapy application to patients suffering from COVID-19 and/or post-COVID-19 syndrome. Materials and methods: A review of the available literature was performed, including reports, articles, feedback letters regarding the application of Deep Oscillation® therapy. The search for scientific articles was conducted in the bibliographic database of Pub Med, Google Scholar, Elsevier. Results matching the following keywords were searched: Deep Oscillation® therapy, low-frequency and low-intensity electrostatic field, COVID-19, COVID-pneumonia, post-COVID-19 syndrome, long COVID, post-acute sequelae of SARS-CoV-2 infection, chronic COVID syndrome, diseases of the respiratory system, pneumonia, obstructive bronchitis, asthma, edema, lymphedema, musculoskeletal symptoms after COVID-19, chronic pain, myalgia, arthralgia, chronic back pain, fatigue. Results: The review made found evidence regarding the anti-inflammatory, anti-edematous, pain-reducing, and anti-fibrotic effects observed with the application of Deep Oscillation® in various diseases, including such of lungs. At this time, no research data were found regarding the application of Deep Oscillation® in patients with COVID-19 or after illness except for a brief communication in the form of a feedback letter regarding the therapy application in individual clinical cases of patients with COVID -19. Conclusion: The scientific studies carried out so far testify of established anti-inflammatory, -swelling and pain-reducing effects, fibrosis reduction possibilities, muscle spasm reduction, local microcirculation improvement and anti-lymphedematous effects of Deep Oscillation® application in various diseases, including lung diseases. These data suggest that a possible positive effect of the low-frequency electrostatic field can also be assumed in patients with COVID-19. Now, however, there are no clinical studies conducted about the Deep Oscillation® application effect in patients with COVID-19 and post COVID-19. Low-frequency electrostatic field therapy is probably an appropriate adjuvant therapy but cannot be recommended as a therapeutic modality in daily clinical practice in patients with COVID-19 due to the lack of reported therapeutic benefits in scientific reports. In the presence of convincing scientific evidence, this opinion is subject to correction. At the same time, it would be appropriate to determine the benefit of this therapy in post-COVID-19 recovery and persistent arthralgia and musculoskeletal symptoms.

show abstract

Section: Introductionmentioning

confidence: 99%

Deep Oscillation® Therapy - Can It Be Effective in Patients With Covid-19 and Post - Covid Syndrome

Мratskova

2022

MEDIS

View full text Add to dashboard Cite

show abstract

“…16 The studies of A. V. Kulish proved that TMS effectively acts on the regulatory mechanisms in the central nervous system, 17 including the hormonal mechanisms involved in carbohydrate and lipid metabolism, while LFEF stimulates antioxidant and microcirculatory processes. 18 In the metabolic syndrome, changes in these processes largely explain the multiplicity of pathological manifestations, therefore the possibility of a simultaneous correction is of great clinical interest. However, to our knowledge there are currently no studies that have investigated how these two noninvasive techniques can act simultaneously on patients with metabolic syndrome.…”

mentioning

confidence: 99%

Simultaneous application of transcranial magnetic stimulation and low-frequency electrostatic field as treatment of carbohydrate and lipid disorders in patients with metabolic syndrome

Benkov¹,

Nagornev²,

Frolkov³

et al. 2022

Eur J Transl Myol

View full text Add to dashboard Cite

The metabolic syndrome, which covers a wide variety of pathological concerns, is rapidly becoming a global pandemic. This syndrome is difficult to treat pharmacologically. Physiotherapy techniques, which have both local and systemic effects, can be employed as a suitable substitute. The purpose of this study was to investigate the therapeutic effects of a program of simultaneous physiotherapy that included migrant transcranial magnetic stimulation (TMS) and the exposure to an alternating low-frequency electrostatic field (LFEF) in the treatment of metabolic syndrome patients. Ninety patients were randomly assigned to three study groups. While continuing the usual drug therapy the first group (30 patients) received LFEF intervention, the second group (30 patients) received TMS, and the third group (30 patients) underwent the simultaneous use of these non-invasive techniques (LFEF + TMS). All treatments involved 10 sessions with daily frequency. In all the patients before and after treatment body weight, blood pressure parameters, levels of insulin, cortisol, glucose, total cholesterol, high density lipoproteins, malondialdehyde, and Schiff bases, the activity of the antioxidant enzymes catalase and of the superoxide dismutase were studied. The changes in the outcomes assessed revealed a different reaction to therapy with LFEF or TMS, as well as a greater benefit when both treatments were used at the same time. A simultaneous LFEF and TMS intervention seems a promising resource for the treatment of the metabolic syndrome, particularly of the lipid and carbohydrate metabolism disorders. However, further studies are needed to confirm these findings and investigate the underlying mechanisms.

show abstract